Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
Kenichi Sugihara(Toujinkai Hospital), Yukihide Kanemitsu(National Cancer Center), Masahiro Igarashi(The Cancer Institute Hospital), Kenjiro Kotake(Tokyo Medical and Dental University), Nobuo Koinuma(Aomori Prefectural Central Hospital), Keiichi Takahashi(Tokyo Metropolitan Komagome Hospital), Naohiko YAMAGUCHI(Seirei Sakura Citizen Hospital), Masahiko Oguchi(Kyorin University), Takayuki Morita(Aomori Prefectural Central Hospital), Michio Itabashi(Tokyo Women's Medical University), Yutaka Saito(National Cancer Center), Yoichi Ajioka(Niigata University), Hideki Ueno(National Defense Medical College), Yoshiharu Sakai(The Japanese Society of Gastroenterological Surgery), Takayuki Yoshino(University of Tsukuba), Toshiharu Yamaguchi(Seirei Sakura Citizen Hospital), Kei Muro(Aichi Cancer Center), Yasuo Ohkura(Kyorin University), Megumi Ishiguro(Tokyo Medical and Dental University), Shinji Tanaka(Onomichi General Hospital), Masahiro Yoshida(Toho University), Hideyuki Ishida(Tokyo Medical and Dental University), Yoshinori Ito(National Cancer Center Hospital East), Yasuhiro Shimada(Tokyo Metropolitan Komagome Hospital), Toshiaki Watanabe(National Center For Child Health and Development), Atsushi Ochiai(Tokyo University of Science), Norihiro Kokudo(The Cancer Institute Hospital), Takahiro Fujimori(Hyogo Social Welfare Corporation), Yuh Sakata(Misawa City Hospital), Osamu Tsuruta(Kurume University), Genichi Nishimura(Misawa City Hospital), Tetsuya Hamaguchi(National Cancer Center Hospital East), Hiroya Takiuchi(Kurume University), Ichinosuke Hyodo(Shikoku Cancer Center)
Cited by 713
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k